Finally, to directly establish the role of IL-1β in modulating CCR5 expression via miR-103 in the context of HIV-1 infection, we pretreated MDMs with the Supnt alone or in the presence of either neutralizing anti-IL-1β, anti-TNF-α, or a combination of both antibodies (Abs). This evidence concerns the gene IL1B and HIV-1 infection.